Medicines Australia publishes Annual Report and announces new Board Directors
29 October 2025: Medicines Australia has published their Annual Report for the year ended 30 June 2025 and welcomed two new Directors to its Board, at their Annual General Meeting (AGM) today.
Joana De Castro (Senior Vice President and Managing Director ANZ, Johnson & Johnson Innovative Medicine) and Melissa McGregor (General Manager, ANZ, Chiesi Australia), have been elected to join the Board. They replace Nathalie McNeil (Vice President and General Manager ANZ, AbbVie) and Josie Downey (General Manager and Managing Director, Merck), who both served for a full 3 year term.
Chair and Director of Medicines Australia, Sue MacLeman, welcomed the newly elected Directors at the AGM.
“On behalf of the Board and the Medicines Australia membership, I congratulate and welcome the newly elected Directors” Sue MacLeman said.
“I sincerely thank the outgoing Directors for their leadership and bringing valuable experience and insight to the Board. We are very grateful for their service and contributions.”
At the AGM, Ms MacLeman shared her first report as Chair for Medicines Australia, articulated the organisation’s progress over the past financial year and thanked members for their welcome and ongoing contributions to Medicines Australia. Ms MacLeman said “Thankyou for your ongoing commitment and contribution to Medicines Australia. I am confident in the strength and unity of our Board, members, and leadership team. Together, we will continue to champion policies that support innovation, a sustainable and thriving innovative medicines sector in Australia, and better health outcomes for all Australians.”
Medicines Australia Annual Report 2024-2025
Media enquiries to: Anne-Marie Sparrow, Medicines Australia /Cube – media@medicinesaustralia.com.au or 0417 421 560
About Medicines Australia
Medicines Australia leads the research-based pharmaceutical industry of Australia. Our members discover, develop and manufacture the medicines that are the foundation of a healthy and prosperous society, including prescription pharmaceutical products, biotherapeutic products and vaccines. Our members invest in Australian medical research and take local discoveries and developments to the world.